-
- Posted Wednesday March 5, 2014
Arizona Myeloma Network hosts 8th annual 'Living with Myeloma' Conference
Experts from TGen, Mayo Clinic among participants at free forum March 22 in Scottsdale
GLENDALE, Ariz. - March 5, 2014 - The Arizona
Myeloma Network (AZMN) will host its 8th annual "Living with
Myeloma" Conference on Saturday, March 22, from 8 a.m.-4:30 p.m. at
the Chaparral Suites Ballroom, 5001 N. Scottsdale Road, Scottsdale,
Ariz.
The free regional conference is open to all patients, caregivers,
family, friends and health care professionals who want to learn
more about this rare and often misdiagnosed bone marrow
cancer.
Each year, nearly 300 participants attend the dynamic "Living with
Myeloma" Conference, which provides cutting-edge information about
the latest myeloma research and the newest and most exciting
therapies for myeloma cancer patients.
The conference details information about transplant therapy and
other new treatment options, including clinical trial
opportunities. It also provides a unique opportunity for cancer
constituents to share knowledge and collaborate.
Registration is available online at http://azmyelomanetwork.org/what/2014confreg.html.
On-site registration at the conference is 8-9 a.m.
Free continental breakfast and lunch will be provided. Medical
professionals may receive 5.75 CME credits.
This year, the conference acknowledges Scottsdale's recent
establishment of its "Cure Corridor," which includes many top-tier
healthcare providers and researchers assembled along and near Shea
Boulevard in the West's Most Western Town.
"Our myeloma conferences have become an important opportunity for
patients and families to learn about this rare form of blood cancer
and feel less alone," says Barbara Kavanagh, Founder and President
of the Arizona Myeloma Network.
The medical faculty for the conference includes: Dr. John Carpten,
Translational Genomics Research Institute (TGen);
Dr. Robert Kyle, Mayo Clinic, Rochester; Dr. Kenneth Anderson, Dana
Farber Cancer Institute, Boston MA; Dr. Frits Van Rhee, UAMS; as
well as other outstanding leaders from Banner MD Anderson Cancer
Center, Scottsdale Healthcare, Cancer Treatment Centers of America,
and local oncology researchers, community physicians, healthcare
professionals and the business community.
"The AZMN conference each year provides an outstanding forum for
all of those concerned with this debilitating and deadly type of
cancer to become better informed about the latest scientific
discoveries and the best medical options that might be available,"
said Dr. Carpten, TGen Deputy Director of Basic Science and
Director of TGen's Integrated Cancer Genomics Division.
###
About Arizona Myeloma Network
Myeloma is a complex and often misdiagnosed cancer of bone marrow
plasma cells that attacks and destroys the bone. Founded in
2004, the Arizona Myeloma Network (AZMN) is a 501(c)(3) nonprofit
charity organization that conducts outreach events and education
programs, with special consideration for the underserved
African-American, Asian-Pacific, Hispanic American and Native
American populations. Volunteers and donations are always
welcomed - see www.azmyelomanetwork.org.
Media Contact:
Barbara Kavanagh, AzMN Founder/President
Phone: (623) 388-6837; Fax: (623) 243-6580
[email protected]
*
About TGen
Translational Genomics Research Institute (TGen) is a Phoenix,
Arizona-based non-profit organization dedicated to conducting
groundbreaking research with life changing results. TGen is focused
on helping patients with cancer, neurological disorders and
diabetes, through cutting edge translational research (the process
of rapidly moving research towards patient benefit). TGen
physicians and scientists work to unravel the genetic components of
both common and rare complex diseases in adults and children.
Working with collaborators in the scientific and medical
communities literally worldwide, TGen makes a substantial
contribution to help our patients through efficiency and
effectiveness of the translational process. For more information,
visit:www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]
